Skip to main content
TipRanks
Go Ultimate75% OFF

Universal (UVV) AI Stock Analysis

4 Followers
DE:UVV

Universal

(Frankfurt:UVV)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Contracted global tobacco supply modelLong-standing B2B relationships and specification-based contracts can support recurring demand and make Universal an embedded supplier for major tobacco manufacturers. Its sourcing, processing, storage and logistics capabilities also create service value beyond selling raw agricultural inputs.
Negative Factors
Broad revenue and profit deteriorationThe decline spans revenue, operating income and net income, showing that current weakness is affecting the consolidated business rather than a single isolated metric. Persistently lower earnings would reduce internal funding capacity and make recovery dependent on improved shipments and execution.

Universal (UVV) vs. iShares MSCI Germany ETF (EWG)

-20%-15%-10%-5%0%5%10%15%DE:UVV-18.63%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 941.49M
Dividend Yield
8.68%
Average Volume (3M)
206
Price to Earnings (P/E)
-377.7
Beta (1Y)
0.12
Revenue Growth
-13.73%
EPS Growth
-101.77%
Country
Germany
Employees
11,250
Sector
Consumer Defensive
Sector Strength
62
Industry
Tobacco

Universal Business Overview & Revenue Model

Company Description

Universal Corporation is a global agricultural enterprise specializing in the processing and supply of leaf tobacco and a diverse range of plant-based ingredients. Its activities are organized into two primary segments: Tobacco Operations and Ingredi...

Universal Earnings Call Summary

Earnings Call Date:Nov 04, 2026(Q2-2027)|% Change Since:-2.57%|Next Earnings Date:Feb 10, 2027
Earnings Call SentimentNeutral

The call presented a mixed outlook. Current results were significantly weaker, with double-digit revenue declines, lower operating income and net income, an Ingredients operating loss, higher net debt and persistent market and supply challenges. These issues were balanced by management's confidence in second-half tobacco shipments, inventory reduction, potential additional customer demand, expected margin improvement, strong liquidity and ongoing long-term transformation initiatives.

Positive Updates

Tobacco Commitments and Inventory Progress
Customer commitments remained in line with the full-year sales plan. Uncommitted inventory declined to 19% as of September 30, within the company's target range, and estimated unsold flue-cured and burley stocks were approximately 134 million kilos, down approximately 45 million kilos from June 30.

Negative Updates

Tobacco Operations Revenue and Profit Declines
Second-quarter Tobacco Operations revenue was $534 million, down 19% year over year, while segment operating income was $44 million compared with $65 million. First-half revenue was $972 million, down 17%, and segment operating income was $47 million, down 53%. Lower tobacco shipment volume was the primary reason, as customers delivered shipping instructions later in the market cycle because of the shift to market oversupply.

Company Guidance

Management expects shipments and financial results to be heavily weighted to the second half, particularly the third and fourth quarters, with uncommitted inventories reducing further from 19% within the target range as of September 30. Gross profit percent of revenue is expected to remain inside the 17% to 19% range, tobacco operating margin is forecast to show some improvement and be comparable with fiscal '26, again within that kind of 17% to 19% range, SG&A is expected to be between $300 million and $310 million, and the $70 million range for interest expense was described as a pretty fair way to see it based on year-to-date interest expense and trend. Additional El Niño-related sales opportunities would be in addition to the sales plan but were not quantified, while working capital usage is expected to moderate, with an aim to delever the balance sheet and reduce interest expense. The Ingredients initiatives are expected to continue through next fiscal year, although management said it is difficult to say exactly how results will play out quarter by quarter.

Universal Risk Analysis

Universal disclosed 24 risk factors in its most recent earnings report. Universal reported the most risks in the "Production" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

0 New Risks

Universal Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

DE:UVV against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
BTIBTI68Neutral$130.64B15.9513.38%5.34%4.47%117.22%
PMPM68Neutral$306.53B29.05-119.68%3.02%7.91%24.06%
MOMO65Neutral$129.61B16.25-279.72%5.46%2.41%-7.63%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
TPBTPB59Neutral$1.11B39.126.97%0.57%23.78%-51.37%
XXIIXXII46Neutral$716.12K0.00-20.47%―-27.44%99.95%

* Consumer Defensive Sector Average

Performance Comparison

-100%-50%0%DE:UVVMOBTIPMXXIITPBDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:UVV and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:UVVUniversal Corporation34.10-8.52-19.99%
MOAltria78.6424.1944.43%
BTIBritish American Tobacco61.8910.2519.86%
PMPhilip Morris International198.9651.4234.85%
XXII22nd Century Group0.77-15271.22-99.99%
TPBTurning Point Brands Inc55.55-44.97-44.74%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.